Skip to main content
Have a personal or library account? Click to login
MicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancer Cover

MicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancer

Radiology and Oncology
Volume 47 (2013): Issue 4 (December 2013)
By:  and    
Open Access
|Oct 2013
References

References

  1. 1. Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review2012;143-59.
    Open DOISearch in Google Scholar
  2. 2. Mattick JS. The Genetic Signatures of Noncoding RNAs2009;.
    Open DOISearch in Google Scholar
  3. 3. Eddy SR. Non-coding RNA genes and the modern RNA world2001;919-29.
    Open DOISearch in Google Scholar
  4. 4. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions2009;155-9.
    Open DOISearch in Google Scholar
  5. 5. Kapranov P, Drenkow J, Cheng J, Long J, Helt G, Dike S, et al. Examples of the complex architecture of the human transcriptome revealed by RACE and high-density tiling arrays2005;987-97.
    Open DOISearch in Google Scholar
  6. 6. Sana J, Faltejskova P, Svoboda M, Slaby O. Novel classes of non-coding RNAs and cancer2012;103
    Open DOISearch in Google Scholar
  7. 7. Zen K, Zhang CY. Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancers2012;326-48.
    Open DOISearch in Google Scholar
  8. 8. Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS. Non-coding RNAs: regulators of disease2010;126-39.
    Open DOISearch in Google Scholar
  9. 9. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids-the mix of hormones and biomarkers2011;467-77.
    Open DOISearch in Google Scholar
  10. 10. Rinn JL, Chang HY. Genome regulation by long noncoding RNAs2012;145-66.
    Search in Google Scholar
  11. 11. Siomi MC, Sato K, Pezic D, Aravin AA. PIWI-interacting small RNAs: the vanguard of genome defence2011;246-58.
    Open DOISearch in Google Scholar
  12. 12. Williams GT, Farzaneh F. Are snoRNAs and snoRNA host genes new players in cancer?2012;84-8.
    Search in Google Scholar
  13. 13. Montanaro L, Trere D, Derenzini M. Nucleolus, ribosomes, and cancer2008;301-10.
    Open DOISearch in Google Scholar
  14. 14. Lares MR, Rossi JJ, Ouellet DL. RNAi and small interfering RNAs in human disease therapeutic applications2010;570-9.
    Open DOISearch in Google Scholar
  15. 15. Mesojednik S, Kamensek U, Cemazar M. Evaluation of shRNA-mediated gene silencing by electroporation in LPB fibrosarcoma cells2008;82-92.
    Open DOISearch in Google Scholar
  16. 16. Wu XY, Zhong DX, Lin B, Zhai WL, Ding ZQ, Wu J. p38 MAPK regulates the expression of ether a go-go potassium channel in human osteosarcoma cells2013;42-9.
    Open DOISearch in Google Scholar
  17. 17. Zhao SH, Zhao F, Zheng JY, Gao LF, Zhao XJ, Cui MH. Knockdown of stat3 expression by RNAi inhibits in vitro growth of human ovarian cancer2011;196-203.
    Open DOISearch in Google Scholar
  18. 18. Hui A, How C, Ito E, Liu FF. Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies2011;500
    Open DOISearch in Google Scholar
  19. 19. Bustin SA, Murphy J. RNA biomarkers in colorectal cancer2013;116-25.
    Open DOISearch in Google Scholar
  20. 20. Bresters D, Schipper MEI, Reesink HW, Boesernunnink BDM, Cuypers HTM. The Duration of Fixation Influences the Yield of Hcv Cdna-Pcr Products from Formalin-Fixed, Paraffin-Embedded Liver-Tissue1994;267-72.
    Open DOISearch in Google Scholar
  21. 21. Cronin M, Pho M, Dutta D, Stephans JC, Shak S, Kiefer MC, et al. Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay2004;35-42.
    Open DOISearch in Google Scholar
  22. 22. Nelson PT, Baldwin DA, Scearce LM, Oberholtzer JC, Tobias JW, Mourelatos Z. Microarray-based, high-throughput gene expression profiling of microRNAs2004;155-61.
    Open DOISearch in Google Scholar
  23. 23. Hui AB, Shi W, Boutros PC, Miller N, Pintilie M, Fyles T, et al. Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues2009;597-606.
    Open DOISearch in Google Scholar
  24. 24. Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH, et al. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene2008;4373-9.
    Open DOISearch in Google Scholar
  25. 25. Asangani IA, Rasheed SAK, Nikolova DA, Leupold JH, Colburn NH, Post S, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer2008;2128-36.
    Open DOISearch in Google Scholar
  26. 26. Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, Schwartz G, et al. Altered microRNA expression confined to specific epithelial cell Subpopulations in breast cancer2007;11612-20.
    Open DOISearch in Google Scholar
  27. 27. Roth C, Rack B, Muller V, Janni W, Pantel K, Schwarzenbach H. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer2010;R90.
    Open DOISearch in Google Scholar
  28. 28. Wang FJ, Zheng ZG, Guo JF, Ding XF. Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor2010;586-93.
    Open DOISearch in Google Scholar
  29. 29. Heneghan HM, Miller N, Kelly R, Newell J, Kerin MJ. Systemic miRNA-195 Differentiates Breast Cancer from Other Malignancies and Is a Potential Biomarker for Detecting Noninvasive and Early Stage Disease2010;673-82.
    Open DOISearch in Google Scholar
  30. 30. Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, et al. Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non-Small-Cell Lung Carcinoma2009;2030-7.
    Open DOISearch in Google Scholar
  31. 31. Roth C, Kasimir-Bauer S, Pantel K, Schwarzenbach H. Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer2011;281-91.
    Open DOISearch in Google Scholar
  32. 32. Xiao BX, Guo JM, Miao Y, Jiang Z, Huan R, Zhang YY, et al. Detection of miR-106a in gastric carcinoma and its clinical significance2009;97-102.
    Open DOISearch in Google Scholar
  33. 33. Zhang YY, Guo JM, Li D, Xiao BX, Miao Y, Jiang Z, et al. Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance2010;685-9.
    Open DOISearch in Google Scholar
  34. 34. Zhang CN, Wang C, Chen X, Yang CH, Li K, Wang JJ, et al. Expression Profile of MicroRNAs in Serum: A Fingerprint for Esophageal Squamous Cell Carcinoma2010;1871-9.
    Open DOISearch in Google Scholar
  35. 35. Liu R, Zhang CN, Hu ZB, Li G, Wang C, Yang CH, et al. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis2011;784-91.
    Open DOISearch in Google Scholar
  36. 36. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis2007;1901-8.
    Open DOISearch in Google Scholar
  37. 37. Habbe N, Koorstra JBM, Mendell JT, Offerhaus GJ, Ryu JK, Feldmann G, et al. MicroRNA miR-155 is a biomarker of early pancreatic neoplasia2009;340-6.
    Open DOISearch in Google Scholar
  38. 38. du Rieu MC, Torrisani J, Selves J, Al Saati T, Souque A, Dufresne M, et al. MicroRNA-21 Is Induced Early in Pancreatic Ductal Adenocarcinoma Precursor Lesions2010;603-12.
    Open DOISearch in Google Scholar
  39. 39. Kong XY, Du YQ, Wang GK, Gao J, Gong YF, Li L, et al. Detection of Differentially Expressed microRNAs in Serum of Pancreatic Ductal Adenocarcinoma Patients: miR-196a Could Be a Potential Marker for Poor Prognosis2011;602-9.
    Open DOISearch in Google Scholar
  40. 40. Ho AS, Huang X, Cao HB, Christman-Skieller C, Bennewith K, Le QT, et al. Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer2010;109-13.
    Search in Google Scholar
  41. 41. Wang J, Chen JY, Chang P, LeBlanc A, Li DH, Abbruzzesse JL, et al. MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease2009;807-13.
    Open DOISearch in Google Scholar
  42. 42. Shi XB, Xue L, Yang J, Ma AH, Zhao J, Xu M, et al. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells2007;19983-8.
    Open DOISearch in Google Scholar
  43. 43. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, et al. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities2008;1271-7.
    Open DOISearch in Google Scholar
  44. 44. Saini S, Majid S, Yamamura S, Tabatabai L, Suh SO, Shahryari V, et al. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis2011;5287-98.
    Open DOISearch in Google Scholar
  45. 45. Hagman Z, Larne O, Edsjo A, Bjartell A, Ehrnstrom RA, Ulmert D, et al. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions2010;2768-76.
    Open DOISearch in Google Scholar
  46. 46. Spahn M, Kneitz S, Scholz CJ, Stenger N, Rudiger T, Strobel P, et al. Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence2010;394-403.
    Search in Google Scholar
  47. 47. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection2008;10513-8.
    Open DOISearch in Google Scholar
  48. 48. Brase JC, Johannes M, Schlomm T, Falth M, Haese A, Steuber T, et al. Circulating miRNAs are correlated with tumor progression in prostate cancer2011;608-16.
    Open DOISearch in Google Scholar
  49. 49. Zhang HL, Yang LF, Zhu Y, Yao XD, Zhang SL, Dai B, et al. Serum miRNA-21: Elevated Levels in Patients With Metastatic Hormone-Refractory Prostate Cancer and Potential Predictive Factor for the Efficacy of Docetaxel-Based Chemotherapy2011;326-31.
    Open DOISearch in Google Scholar
  50. 50. Agaoglu FY, Kovancilar M, Dizdar Y, Darendeliler E, Holdenrieder S, Dalay N, et al. Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer2011;583-8.
    Open DOISearch in Google Scholar
  51. 51. Bryant RJ, Pawlowski T, Catto JWF, Marsden G, Vessella RL, Rhees B, et al. Changes in circulating microRNA levels associated with prostate cancer2012;768-74.
    Open DOISearch in Google Scholar
  52. 52. Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S, et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas2005;243-9.
    Open DOISearch in Google Scholar
  53. 53. Huang ZH, Huang D, Ni SJA, Peng ZL, Sheng WQ, Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer2010;118-26.
    Open DOISearch in Google Scholar
  54. 54. Cheng HY, Zhang LN, Cogdell DE, Zheng H, Schetter AJ, Nykter M, et al. Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis2011;e17745.
    Open DOISearch in Google Scholar
  55. 55. Ferracin M, Pedriali M, Veronese A, Zagatti B, Gafa R, Magri E, et al. MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin2011;43-53.
    Open DOISearch in Google Scholar
  56. 56. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis2010;1071-6.
    Open DOISearch in Google Scholar
  57. 57. Geng YJ, Xie SL, Li Q, Ma J, Wang GY. Large Intervening Non-coding RNA HOTAIR is Associated with Hepatocellular Carcinoma Progression2011;2119 - 28.
    Open DOISearch in Google Scholar
  58. 58. Yu W, Gius D, Onyango P, Muldoon-Jacobs K, Karp J, Feinberg AP, et al. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA2008;202-6.
    Open DOISearch in Google Scholar
  59. 59. Chen W, Böcker W, Brosius J, Tiedge H. Expression of neural BC200 RNA in human tumours1997;345-51.
    Open DOISearch in Google Scholar
  60. 60. Iacoangeli A, Lin Y, Morley EJ, Muslimov IA, Bianchi R, Reilly J, et al. BC200 RNA in invasive and preinvasive breast cancer2004;2125-33.
    Open DOISearch in Google Scholar
  61. 61. Chung S, Nakagawa H, Uemura M, Piao L, Ashikawa K, Hosono N, et al. Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility2011;245-52.
    Open DOISearch in Google Scholar
  62. 62. Gabory A, Jammes H, Dandolo L. The H19 locus: role of an imprinted noncoding RNA in growth and development2010;473-80.
    Open DOISearch in Google Scholar
  63. 63. Hibi K, Nakamura H, Hirai A, al. e. Loss of H19 imprinting in esophageal cancer1996;480-2.
    Search in Google Scholar
  64. 64. Fellig Y, Ariel I, Ohana P, Schachter P, Sinelnikov I, Birman T, et al. H19 expression in hepatic metastases from a range of human carcinomas2005;1064-8.
    Open DOISearch in Google Scholar
  65. 65. Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, Hochberg A, et al. The H19 non-coding RNA is essential for human tumor growth2007;e845.
    Open DOISearch in Google Scholar
  66. 66. Arima T, Matsuda T, Takagi N, Wake N. Association of IGF2 and H19 imprinting with choriocarcinoma development1997;39-47.
    Open DOISearch in Google Scholar
  67. 67. Berteaux N, Lottin S, Monte D, Pinte S, Quatannens B, Coll J, et al. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F12005;29625-36.
    Open DOISearch in Google Scholar
  68. 68. Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL, et al. The c-Myc oncogene directly induces the H19 noncoding RNA by allelespecific binding to potentiate tumorigenesis2006;5330-7.
    Open DOISearch in Google Scholar
  69. 69. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, et al. Long noncoding RNA as modular scaffold of histone modification complexes2010;689-93.
    Open DOISearch in Google Scholar
  70. 70. Yang Z, Zhou L, Wu LM, Lai MC, Xie HY, Zhang F, et al. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation2011;1243-50.
    Open DOISearch in Google Scholar
  71. 71. Matouk IJ, Abbasi I, Hochberg A, Galun E, Dweik H, Akkawi M. Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis2009;688-92.
    Open DOISearch in Google Scholar
  72. 72. Panzitt K, Tschernatsch MM, Guelly C, Moustafa T, Stradner M, Strohmaier HM, et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA2007;330-42.
    Open DOISearch in Google Scholar
  73. 73. Guffanti A, Iacono M, Pelucchi P, Kim N, Solda G, Croft LJ, et al. A transcriptional sketch of a primary human breast cancer by 454 deep sequencing2009;163
    Open DOISearch in Google Scholar
  74. 74. Yamada K, Kano J, Tsunoda H, Yoshikawa H, Okubo C, Ishiyama T, et al. Phenotypic characterization of endometrial stromal sarcoma of the uterus2006;106-12.
    Open DOISearch in Google Scholar
  75. 75. Lin R, Maeda S, Liu C, Karin M, Edgington TS. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas2007;851-8.
    Open DOISearch in Google Scholar
  76. 76. Luo JH, Ren B, Keryanov S, Tsang GC, Reo UNM, Monga SP, et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas2006;1012-24.
    Open DOISearch in Google Scholar
  77. 77. Gejman R, Batista DL, Zhong Y, Zhou Y, Zhang X, Swearingen B, et al. Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas2008;4119-25.
    Open DOISearch in Google Scholar
  78. 78. Benetatos L, Vartholomatos G, Hatzimichael E. MEG3 imprinted gene contribution in tumorigenesis2011;773-9.
    Open DOISearch in Google Scholar
  79. 79. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology2010;1033-8.
    Open DOISearch in Google Scholar
  80. 80. Khaitan D, Dinger ME, Mazar J, Crawford J, Smith MA, Mattick JS, et al. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion2011;3852-62.
    Open DOISearch in Google Scholar
  81. 81. Lanz RB, Chua SS, Barron N, Soder BM, DeMayo F, O’Malley BW. Steroid Receptor RNA Activator Stimulates Proliferation as Well as Apoptosis In Vivo2003;7163-76.
    Open DOISearch in Google Scholar
  82. 82. Chooniedass-Kothari S, Vincett D, Yan Y, Cooper C, Hamedani MK, Myal Y, et al. The protein encoded by the functional steroid receptor RNA activator is a new modulator of ER alpha transcriptional activity2010;1174-80.
    Open DOISearch in Google Scholar
  83. 83. Wang F, Li X, Xie X, Zhao L, Chen W. UCA1, a non-protein-coding RNA upregulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion2008;1919-27.
    Open DOISearch in Google Scholar
  84. 84. Wang XS, Zhang Z, Wang HC, Cai JL, Xu QW, Li MQ, et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma2006;4851-8.
    Open DOISearch in Google Scholar
  85. 85. de Kok JB, Verhaegh GW, Roelofs RW, Hessels D, Kiemeney LA, Aalders TW, et al. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors2002;2695-89.
    Search in Google Scholar
  86. 86. Mourtada-Maarabouni M, Pickard MR, Hedge VL, Farzaneh F, Williams GT. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer2009;195-208.
    Open DOISearch in Google Scholar
  87. 87. Yap KL, Li S, Munoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a2010;662-74.
    Open DOISearch in Google Scholar
  88. 88. Rajaram V, Knezevich S, Bove KE, Perry A, Pfeifer JD. DNA sequence of the translocation breakpoints in undifferentiated embryonal sarcoma arising in mesenchymal hamartoma of the liver harboring the t(11;19)(q11;q13.4) translocation2007;508-13.
    Open DOISearch in Google Scholar
  89. 89. Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation2012;1810-6.
    Open DOISearch in Google Scholar
  90. 90. Kino T, Hurt DE, Ichijo T, Nader N, Chrousos GP. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor2010;ra8.
    Open DOISearch in Google Scholar
  91. 91. Marks LS, Fradet Y, Deras IL, Blase A, Mathis J, Aubin SMJ, et al. PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy2007;532-5.
    Open DOISearch in Google Scholar
  92. 92. Tinzl M, Marberger M, Horvath S, Chypre C. DD3PCA3 RNA Analysis in Urine - a new perspective for detecting prostate cancer2004;182-7.
    Open DOISearch in Google Scholar
  93. 93. Neves AF, Dias-Oliveira JDD, Araujo TG, Marangoni K, Goulart LR. Prostate cancer antigen 3 (PCA3) RNA detection in blood and tissue samples for prostate cancer diagnosis2013;881-7.
    Open DOISearch in Google Scholar
  94. 94. Oberg AL, French AJ, Sarver AL, Subramanian S, Morlan BW, Riska SM, et al. miRNA Expression in Colon Polyps Provides Evidence for a Multihit Model of Colon Cancer2011;: e20465.
    Open DOISearch in Google Scholar
  95. 95. Kent OA, Mendell JT. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes2006;6188-96.
    Open DOISearch in Google Scholar
  96. 96. Kota SK, Balasubramanian S. Cancer therapy via modulation of micro RNA levels: a promising future2010;733-40.
    Open DOISearch in Google Scholar
  97. 97. Bader AG, Brown D, Stoudemire J, Lammers P. Developing therapeutic microRNAs for cancer2011;1121-6.
    Open DOISearch in Google Scholar
  98. 98. Broderick JA, Zamore PD. MicroRNA therapeutics2011;1104-10.
    Open DOISearch in Google Scholar
  99. 99. Croce CM. Causes and consequences of microRNA dysregulation in cancer2009;704-14.
    Open DOISearch in Google Scholar
  100. 100. Bader AG, Brown D, Winkler M. The Promise of MicroRNA Replacement Therapy2010;7027-30.
    Open DOISearch in Google Scholar
  101. 101. Dolinsek T, Markelc B, Sersa G, Coer A, Stimac M, Lavrencak J, et al. Multiple Delivery of siRNA against Endoglin into Murine Mammary Adenocarcinoma Prevents Angiogenesis and Delays Tumor Growth2013;e58723.
    Open DOISearch in Google Scholar
  102. 102. Todorovic V, Sersa G, Cemazar M. Gene electrotransfer of siRNAs against CD146 inhibits migration and invasion of human malignant melanoma cells SK-MEL282013;208-10.
    Open DOISearch in Google Scholar
  103. 103. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. miR-21-mediated tumor growth2007;2799-803.
    Open DOISearch in Google Scholar
  104. 104. Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells2007;721-6.
    Open DOISearch in Google Scholar
  105. 105. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, et al. miR-9, a MYC/ MYCN-activated microRNA, regulates E-cadherin and cancer metastasis2010;247-52.
    Open DOISearch in Google Scholar
  106. 106. Trang P, Medina PP, Wiggins JF, Ruffino L, Kelnar K, Omotola M, et al. Regression of murine lung tumors by the let-7 microRNA2010;1580-7.
    Open DOISearch in Google Scholar
  107. 107. Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA, et al. Suppression of non-small cell lung tumor development by the let-7 micro- RNA family2008;3903-8.
    Open DOISearch in Google Scholar
  108. 108. Ji Q, Hao X, Meng Y, Zhang M, DeSano J, Fan DM, et al. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres2008;266
    Open DOISearch in Google Scholar
  109. 109. Gutschner T, Baas M, Diederichs S. Noncoding RNA gene silencing through genomic integration of RNA destabilizing elements using zinc finger nucleases2011;1944-54.
    Open DOISearch in Google Scholar
  110. 110. Borralho PM, Simoes AES, Gomes SE, Lima RT, Carvalho T, Ferreira DMS, et al. miR-143 Overexpression Impairs Growth of Human Colon Carcinoma Xenografts in Mice with Induction of Apoptosis and Inhibition of Proliferation2011;e23787.
    Open DOISearch in Google Scholar
  111. 111. Mizrahi A, Czerniak A, Levy T, Amiur S, Gallula J, Matouk I, et al. Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences2009;69
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/raon-2013-0062 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 311 - 318
Published on: Oct 8, 2013
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
> microRNAs,
long non-coding RNAs,
diagnosis,
therapy,
biomarker
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2013 Nina Hauptman, Damjan Glavac, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 47 (2013): Issue 4 (December 2013)
Next article